As one kind of antibody-based radiopharmaceuticals, RDC with accurate bifunctional in cancer diagnostic and treatment represents one of the fastest growing fields in the pharmaceutical industry. Many novel bioconjugation approaches have been generated recently. Among all the bioconjugation methods, there are three most prevalent covalent bonds in radionuclide-antibody conjugation.